WHOOP, the Boston-based wearable health technology company, has closed a $575 million Series G funding round that values the company at $10.1 billion — nearly three times its previous $3.6 billion valuation from 2021. The round, led by Collaborative Fund, drew significant backing from Gulf sovereign wealth funds, global healthcare institutions like Abbott and Mayo Clinic, and a star-studded roster of athlete-investors including Cristiano Ronaldo and LeBron James. Proceeds will fund aggressive international expansion, a 600-person hiring spree, the opening of WHOOP Labs Doha, and continued investment in AI-driven preventive health capabilities. CEO Will Ahmed has signaled this will likely be the company’s final private funding round before pursuing an initial public offering.
Key Overview
- Funding amount: $575 million in Series G
- Valuation: $10.1 billion (up from $3.6 billion in 2021)
- Lead investor: Collaborative Fund
- Key GCC investors: Qatar Investment Authority, Mubadala Investment Company, 2PointZero Group
- Strategic healthcare investors: Abbott, Mayo Clinic
- Celebrity investors: Cristiano Ronaldo, LeBron James, Rory McIlroy, Virgil van Dijk, Niall Horan, Shane Lowry, Karen Wazen
- Total capital raised to date: Over $900 million
- Members worldwide: 2.5 million+
- 2025 bookings run rate: $1.1 billion (103% year-over-year growth)
- New hires planned: 600+ roles in 2026
- IPO outlook: Ahmed has indicated this is expected to be WHOOP’s last private round
Markets move fast; don’t get left behind. We’ve paired the Serrari Group Market Index with a curated Marketplace and a comprehensive Wealth Builder Course to ensure you have the data—and the skills—to act on it.
A Landmark Round for Wearable Health Technology
WHOOP announced on March 31, 2026 that it had closed one of the largest private funding rounds ever seen in the wearable technology sector. The $575 million Series G was led by Collaborative Fund and included a broad coalition of institutional investors, sovereign wealth funds, healthcare organizations, and individual backers. The deal values the company at $10.1 billion, which according to TechCrunch represents nearly triple its last reported valuation of $3.6 billion set during a SoftBank-led Series F in August 2021.
The round attracted a remarkable diversity of capital sources. GCC-based investors played a prominent role, with the Qatar Investment Authority, Mubadala Investment Company, and 2PointZero Group all participating. Global institutional backers included Macquarie Capital, Glade Brook, B-Flexion, IVP, Foundry, Accomplice, Affinity Partners, Promus Ventures, and Bullhound Capital.
Perhaps most notable from a strategic standpoint was the entry of healthcare heavyweights Abbott and the Mayo Clinic as investors. Abbott, with its expansive portfolio spanning diagnostics, medical devices, and nutrition, brings deep healthcare expertise and a track record of health technology innovation. Ahmed described their participation as a signal that WHOOP is increasingly viewed as a serious play in the expanding longevity and preventive health space, not merely a fitness gadget company.
A Roster of Elite Athlete Investors
The funding round drew attention not only for its institutional backers but also for its unusually high-profile group of individual investors. Cristiano Ronaldo, who serves as both an investor and global ambassador for WHOOP, participated alongside basketball legend LeBron James, golfers Rory McIlroy and Shane Lowry, footballer Virgil van Dijk, musician Niall Horan, and influencer Karen Wazen.
Ronaldo praised the platform as an integral part of his health regimen, and his involvement underscores the growing overlap between elite sports performance, cultural influence, and health technology. Ahmed has long pursued a strategy of cultivating endorsements from top-tier athletes as a brand-building mechanism. Early in the company’s history, he sought out figures like LeBron James and Olympic swimmer Michael Phelps, getting WHOOP into the hands of their personal trainers. That approach helped position the device as aspirational rather than clinical, building a performance-oriented brand identity that has proven central to WHOOP’s consumer appeal.
According to Yahoo Finance, the capital raise places WHOOP among the most valuable private companies globally, just below Shield AI and Kraken on certain rankings.
Explosive Business Growth
The funding arrives at a moment of exceptional commercial momentum for WHOOP. The company disclosed that it now has over 2.5 million members worldwide and grew bookings by 103 percent year-over-year in 2025, exiting the year at a $1.1 billion bookings run rate. The company also achieved positive operating cash flow in 2025 — a significant milestone for a hardware-plus-subscription business.
WHOOP’s subscription model is central to its financial profile. The wearable device itself is included at no upfront cost with a membership, which as of early 2026 is priced at $239 annually for a standard plan. This creates recurring revenue streams that, when combined with hardware margins and premium tiers, justify a premium valuation.
Ahmed emphasized the importance of bookings as the appropriate metric for evaluating the business. When shipping millions of hardware units globally while running a subscription service, investors need to understand the cash dynamics of managing inventory, hardware costs, and recurring revenue simultaneously — a more complex picture than a typical software company.
The company has now raised more than $900 million in total venture capital since its founding, ships to 56 countries, and operates in six languages.
Context is everything. While you follow today’s updates, use the Serrari Group Market Index and Marketplace to spot emerging shifts. Need to sharpen your edge? Our Wealth Builder Course turns these insights into a professional-grade strategy.
GCC Expansion and WHOOP Labs Doha
A defining element of this funding round is WHOOP’s strategic pivot toward the Gulf Cooperation Council region. The heavy participation of GCC-based investors signals that Gulf capital is taking a more active role in shaping emerging sectors like personalized health technology.
As part of its regional expansion, WHOOP will open WHOOP Labs Doha in the coming months — the company’s first international performance research and development facility. The lab, located in Msheireb Downtown Doha, the world’s first fully built smart and sustainable city district, is being developed in partnership with Invest Qatar. Modeled after WHOOP Labs Boston at the company’s headquarters, the Doha facility will advance research and data collection while enabling partnerships with local institutions for sport performance studies.
Sheikh Ali Alwaleed Al-Thani, CEO of Invest Qatar, characterized the partnership as part of Qatar’s pursuit of a knowledge-based, technology-driven economy. The facility will also undertake joint efforts with WHOOP to attract and cultivate local talent.
Ahmed told The National that the UAE has become one of WHOOP’s most important markets globally, citing extraordinary growth and engagement in the region. He also told Arab News that Saudi Arabia is a hugely important market where the company is seeing tremendous penetration. WHOOP is expanding local teams, growing its retail footprint across multiple GCC markets, and developing partnerships to integrate the platform into broader regional health ecosystems.
The company is also advancing a series of initiatives across the UAE and Qatar designed to accelerate adoption and establish WHOOP as a leader in health and human performance across the region.
From Fitness Wearable to Health Platform
WHOOP’s trajectory over the past several years reflects a deliberate evolution from a niche performance wearable into a comprehensive health platform. The company’s platform is powered by more than 24 billion hours of physiological data and purpose-built AI models that deliver predictive, personalized health insights.
Members engage with the app an average of over eight times per day — almost three times higher than competing screenless wearables — to monitor sleep quality, recovery status, training strain, and the impact of daily behaviors on long-term health. These insights extend beyond fitness, helping users identify early warning signs and take action that can potentially prevent serious health events.
The launch of the WHOOP MG (Medical Grade) device in mid-2025 marked a significant step toward clinical health integration. The device introduced an FDA-cleared ECG sensor capable of checking heart rhythm from the wrist and detecting signs of atrial fibrillation, a condition that many patients experience without symptoms. The MG model also featured enhanced sensors for tracking skin temperature and physiological signals, alongside an AI-powered WHOOP Coach that delivers real-time recommendations.
However, WHOOP’s ambitions in the clinical space have not been without friction. In July 2025, the FDA issued a warning letter over the company’s Blood Pressure Insights feature, asserting that it constituted an unauthorized medical device. WHOOP pushed back, citing the 21st Century Cures Act and arguing that blood pressure data was being used for wellness purposes rather than clinical diagnosis. The dispute generated significant industry debate about the boundaries between wellness tools and regulated medical devices.
The situation shifted in early 2026, when updated FDA guidance under Commissioner Marty Makary expanded general wellness exemptions, allowing blood pressure measurements via optical sensing to remain in the wellness category provided companies make no claims about medical-grade data. The resolution was widely interpreted as a regulatory win for WHOOP and a signal of the FDA’s evolving approach to wearable health technology.
The Competitive Landscape
WHOOP’s mega-round positions it firmly in the upper echelon of wearable health companies, though the competitive landscape is intensifying. Its most direct rival, Finnish smart ring maker Oura, raised $900 million at an $11 billion valuation in October 2025 in a round led by Fidelity. Oura reported selling over 5.5 million rings since launch, with revenue expected to surpass $1 billion in 2025.
The broader market includes tech giants like Apple with its dominant Watch ecosystem, Samsung’s Galaxy Ring, and emerging players like Ultrahuman and RingConn. What distinguishes WHOOP in this crowded field is its subscription-first model, screenless design philosophy, and increasingly deep focus on clinical-grade health data.
Ahmed has framed WHOOP’s approach as fundamentally different from traditional wearables. Rather than competing on display features and notifications, WHOOP focuses entirely on continuous biometric data collection and analysis. The company’s vision is to build a platform that can eventually predict serious health events like heart attacks and strokes, transforming the device from a recovery tool into a genuine preventive health system.
A Massive Hiring Spree
To support its expansion plans, WHOOP is hiring more than 600 new employees in 2026, a move that would increase its workforce by roughly 75 percent from its current base of approximately 800 staff. The roles span software engineering, research and design, hardware development, product management, manufacturing, sales, and marketing. The majority of positions will be based in Boston, with additional recruitment planned across North America, Europe, the GCC, and Asia.
Ahmed framed the expansion as a bet on both human talent and artificial intelligence. He noted that while many companies are debating whether to hire more people or invest in AI, WHOOP is doing both — a stance that reflects the company’s belief that the intersection of human expertise and machine intelligence will define the next generation of health technology.
The Road to IPO
The Series G round has intensified speculation about WHOOP’s path to the public markets. Ahmed told Yahoo Finance that this is expected to be the company’s final private funding round, stating that the business is now cash flow positive and the $575 million significantly strengthens its balance sheet. He told Arab News that WHOOP would be well positioned for an IPO over a horizon of approximately two years.
In a conversation with TechCrunch, Ahmed was somewhat more guarded, saying the company is doing preparatory work to become a public company but stopping short of committing to a specific timeline. With rival Oura also reportedly in discussions with bankers about a potential listing, the wearable health sector could see multiple high-profile IPOs in the coming years.
The Boston Globe noted that it may be prudent for WHOOP to wait out 2026, given market turmoil and global uncertainty, though the company’s strong growth metrics and cash flow position would give it considerable flexibility on timing.
The Origins of WHOOP: From Harvard Squash to $10 Billion
WHOOP’s journey to a $10 billion valuation began with a problem familiar to any serious athlete: overtraining. Will Ahmed, while captaining the Harvard University squash team, found himself repeatedly pushing his body past its limits without understanding why he would suddenly collapse after periods of peak fitness.
That frustration led Ahmed down an academic rabbit hole. He read hundreds of medical papers on physiology and ultimately wrote a detailed paper outlining how continuous measurement of key biometric signals could provide a deep understanding of the human body. That research became the business plan for WHOOP. Ahmed recruited two co-founders with technical backgrounds — John Capodilupo and Aurelian Nicolae — and the trio began building prototypes at the Harvard Innovation Labs in 2012.
The company’s first wearable launched in 2015, and Ahmed pursued a deliberate strategy of selling to professional sports teams and elite athletes before marketing to consumers. The approach generated what he called a halo effect for the brand, positioning WHOOP as aspirational and helping remove the stigma historically associated with health monitoring devices.
Today, Ahmed sits on the Board of Fellows at Harvard Medical School and has been recognized on Forbes 30 Under 30, Fortune 40 Under 40, and Sports Business Journal’s 40 Under 40 lists.
The Bigger Picture: Preventive Health at a Turning Point
WHOOP’s massive funding round arrives at a moment when the preventive health movement is gaining unprecedented institutional support and consumer interest. Chronic disease rates are rising globally, and healthcare systems in many countries remain fundamentally oriented toward reactive treatment rather than prevention. Advances in AI, continuous biometric monitoring, and personalized data analytics are enabling a new model that predicts risk, guides daily behavior, and intervenes before disease takes hold.
The entry of strategic healthcare investors like Abbott and Mayo Clinic into WHOOP’s cap table signals growing institutional confidence that wearable technology can play a meaningful role in transforming healthcare delivery. Ahmed’s stated ambition to eventually predict events like heart attacks and strokes represents the logical endpoint of this trajectory — a future in which a device worn 24 hours a day continuously monitors for early warning signals and alerts users or their physicians before a crisis occurs.
Whether WHOOP can deliver on that vision will depend on continued advances in sensor technology, AI model accuracy, regulatory navigation, and consumer trust. But with $900 million in total capital, a $10.1 billion valuation, and a rapidly growing global membership base, the company has assembled the resources and momentum to make a credible run at building the definitive personal health platform of the next decade.
Your financial future isn’t something you wait for—it’s something you build.
The real question is: when do you begin?
Move beyond simply staying informed.
Navigate the markets with clarity—track trends through the Serrari Group Market Index, uncover opportunities in the Serrari Marketplace, and build practical knowledge with our Curated Wealth Builder Course.
Stay connected to what truly matters.
Get daily insights on macro trends and financial movements across Kenya, Africa, and global markets—delivered through the Serrari Newsletter.
Growth opens doors.
Advance your career through professional programs including ACCA, HESI A2, ATI TEAS 7 , HESI EXIT , NCLEX – RN and NCLEX – PN, Financial Literacy!🌟—designed to move you forward with confidence.
See where money is flowing—clearly and in real time.
Track Money Market Funds, Treasury Bills, Treasury Bonds, Green Bonds, and Fixed Deposits, alongside global and African indexes, key economic indicators, and the evolving Crypto and stablecoin landscape—all within Serrari’s Market Index.
